194 related articles for article (PubMed ID: 35307819)
1. Altered IgG glycosylation at COVID-19 diagnosis predicts disease severity.
Vicente MM; Alves I; Gaifem J; Rodrigues CS; Fernandes Â; Dias AM; Štambuk J; Petrović T; Oliveira P; Ferreira-da-Silva F; Soares A; Seixas N; Teixeira T; Malheiro L; Abreu MM; Lauc G; Sarmento E Castro R; Pinho SS
Eur J Immunol; 2022 Jun; 52(6):946-957. PubMed ID: 35307819
[TBL] [Abstract][Full Text] [Related]
2. IgG N-glycome changes during the course of severe COVID-19: An observational study.
Petrović T; Vijay A; Vučković F; Trbojević-Akmačić I; Ollivere BJ; Marjanović D; Bego T; Prnjavorac B; Đerek L; Markotić A; Lukšić I; Jurin I; Valdes AM; Hadžibegović I; Lauc G
EBioMedicine; 2022 Jul; 81():104101. PubMed ID: 35773089
[TBL] [Abstract][Full Text] [Related]
3. Bulk IgG glycosylation predicts COVID-19 severity and vaccine antibody response.
Ash MK; Bhimalli PP; Cho BK; Mattamana BB; Gambut S; Tarhoni I; Fhied CL; Reyes AF; Welninski SJ; Arivalagan J; Negrão F; Goel R; Beck TL; Hope TJ; Sha BE; Goo YA; Al-Harthi L; Mamede JI; Borgia JA; Kelleher NL; Schneider JR
Cell Rep; 2022 Dec; 41(11):111799. PubMed ID: 36493786
[TBL] [Abstract][Full Text] [Related]
4. The IgG glycome of SARS-CoV-2 infected individuals reflects disease course and severity.
Siekman SL; Pongracz T; Wang W; Nouta J; Kremsner PG; da Silva-Neto PV; Esen M; Kreidenweiss A; Held J; Trapé ÁA; Fendel R; de Miranda Santos IKF; Wuhrer M;
Front Immunol; 2022; 13():993354. PubMed ID: 36389824
[TBL] [Abstract][Full Text] [Related]
5. Immunoglobulin G1 Fc glycosylation as an early hallmark of severe COVID-19.
Pongracz T; Nouta J; Wang W; van Meijgaarden KE; Linty F; Vidarsson G; Joosten SA; Ottenhoff THM; Hokke CH; de Vries JJC; Arbous SM; Roukens AHE; Wuhrer M; ;
EBioMedicine; 2022 Apr; 78():103957. PubMed ID: 35334306
[TBL] [Abstract][Full Text] [Related]
6. Fucosylated N-glycans as early biomarkers of COVID-19 severity.
Paton B; Herrero P; Peraire J; Del Pino A; Chafino S; Martinez-Picado J; Gómez-Bertomeu F; Rull A; Canela N; Suárez M
Front Immunol; 2023; 14():1204661. PubMed ID: 37342334
[TBL] [Abstract][Full Text] [Related]
7. Differences in IgG Fc Glycosylation Are Associated with Outcome of Pediatric Meningococcal Sepsis.
de Haan N; Boeddha NP; Ekinci E; Reiding KR; Emonts M; Hazelzet JA; Wuhrer M; Driessen GJ
mBio; 2018 Jun; 9(3):. PubMed ID: 29921663
[TBL] [Abstract][Full Text] [Related]
8. Fc specific IgG glycosylation profiling by robust nano-reverse phase HPLC-MS using a sheath-flow ESI sprayer interface.
Selman MH; Derks RJ; Bondt A; Palmblad M; Schoenmaker B; Koeleman CA; van de Geijn FE; Dolhain RJ; Deelder AM; Wuhrer M
J Proteomics; 2012 Feb; 75(4):1318-29. PubMed ID: 22120122
[TBL] [Abstract][Full Text] [Related]
9. Synthetic nanobodies as tools to distinguish IgG Fc glycoforms.
Kao KS; Gupta A; Zong G; Li C; Kerschbaumer I; Borghi S; Achkar JM; Bournazos S; Wang LX; Ravetch JV
Proc Natl Acad Sci U S A; 2022 Nov; 119(48):e2212658119. PubMed ID: 36409896
[TBL] [Abstract][Full Text] [Related]
10. IgG Fc N-glycosylation in Guillain-Barré syndrome treated with immunoglobulins.
Fokkink WJ; Selman MH; Dortland JR; Durmuş B; Kuitwaard K; Huizinga R; van Rijs W; Tio-Gillen AP; van Doorn PA; Deelder AM; Wuhrer M; Jacobs BC
J Proteome Res; 2014 Mar; 13(3):1722-30. PubMed ID: 24533874
[TBL] [Abstract][Full Text] [Related]
11. Clinical severity of visceral leishmaniasis is associated with changes in immunoglobulin g fc N-glycosylation.
Gardinassi LG; Dotz V; Hipgrave Ederveen A; de Almeida RP; Nery Costa CH; Costa DL; de Jesus AR; Mayboroda OA; Garcia GR; Wuhrer M; de Miranda Santos IK
mBio; 2014 Dec; 5(6):e01844. PubMed ID: 25467439
[TBL] [Abstract][Full Text] [Related]
12. Changes of IgG
Trzos S; Link-Lenczowski P; Sokołowski G; Pocheć E
Front Immunol; 2022; 13():841710. PubMed ID: 35370997
[TBL] [Abstract][Full Text] [Related]
13. Immunoglobulin G Fc N-glycan profiling in patients with gastric cancer by LC-ESI-MS: relation to tumor progression and survival.
Kodar K; Stadlmann J; Klaamas K; Sergeyev B; Kurtenkov O
Glycoconj J; 2012 Jan; 29(1):57-66. PubMed ID: 22179780
[TBL] [Abstract][Full Text] [Related]
14. Variations in oligosaccharide-protein interactions in immunoglobulin G determine the site-specific glycosylation profiles and modulate the dynamic motion of the Fc oligosaccharides.
Wormald MR; Rudd PM; Harvey DJ; Chang SC; Scragg IG; Dwek RA
Biochemistry; 1997 Feb; 36(6):1370-80. PubMed ID: 9063885
[TBL] [Abstract][Full Text] [Related]
15. Afucosylated IgG characterizes enveloped viral responses and correlates with COVID-19 severity.
Larsen MD; de Graaf EL; Sonneveld ME; Plomp HR; Nouta J; Hoepel W; Chen HJ; Linty F; Visser R; Brinkhaus M; Šuštić T; de Taeye SW; Bentlage AEH; Toivonen S; Koeleman CAM; Sainio S; Kootstra NA; Brouwer PJM; Geyer CE; Derksen NIL; Wolbink G; de Winther M; Sanders RW; van Gils MJ; de Bruin S; Vlaar APJ; ; ; Rispens T; den Dunnen J; Zaaijer HL; Wuhrer M; Ellen van der Schoot C; Vidarsson G
Science; 2021 Feb; 371(6532):. PubMed ID: 33361116
[TBL] [Abstract][Full Text] [Related]
16. Blood plasma IgG Fc glycans are significantly altered in Alzheimer's disease and progressive mild cognitive impairment.
Lundström SL; Yang H; Lyutvinskiy Y; Rutishauser D; Herukka SK; Soininen H; Zubarev RA
J Alzheimers Dis; 2014; 38(3):567-79. PubMed ID: 24028868
[TBL] [Abstract][Full Text] [Related]
17. Serum immunoglobulin G Fc region N-glycosylation profiling by matrix-assisted laser desorption/ionization mass spectrometry can distinguish breast cancer patients from cancer-free controls.
Kawaguchi-Sakita N; Kaneshiro-Nakagawa K; Kawashima M; Sugimoto M; Tokiwa M; Suzuki E; Kajihara S; Fujita Y; Iwamoto S; Tanaka K; Toi M
Biochem Biophys Res Commun; 2016 Jan; 469(4):1140-5. PubMed ID: 26740182
[TBL] [Abstract][Full Text] [Related]
18. Proinflammatory IgG Fc structures in patients with severe COVID-19.
Chakraborty S; Gonzalez J; Edwards K; Mallajosyula V; Buzzanco AS; Sherwood R; Buffone C; Kathale N; Providenza S; Xie MM; Andrews JR; Blish CA; Singh U; Dugan H; Wilson PC; Pham TD; Boyd SD; Nadeau KC; Pinsky BA; Zhang S; Memoli MJ; Taubenberger JK; Morales T; Schapiro JM; Tan GS; Jagannathan P; Wang TT
Nat Immunol; 2021 Jan; 22(1):67-73. PubMed ID: 33169014
[TBL] [Abstract][Full Text] [Related]
19. Impact of Fc N-glycan sialylation on IgG structure.
Zhang Z; Shah B; Richardson J
MAbs; 2019; 11(8):1381-1390. PubMed ID: 31411531
[TBL] [Abstract][Full Text] [Related]
20. Metabolic control of recombinant monoclonal antibody N-glycosylation in GS-NS0 cells.
Hills AE; Patel A; Boyd P; James DC
Biotechnol Bioeng; 2001 Oct; 75(2):239-51. PubMed ID: 11536148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
